Published in J Infect Dis on July 01, 1987
Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ (1994) 4.58
GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med (2013) 3.37
Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis (2000) 1.71
Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea. J Clin Microbiol (2005) 1.67
Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. Open Med (2014) 1.14
Travel patterns and risk behaviour of HIV-positive people travelling internationally. CMAJ (2005) 1.07
Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis (2013) 1.05
Imported enteric fever: case series from the hospital for tropical diseases, London, United Kingdom. Am J Trop Med Hyg (2010) 0.94
Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci (2007) 0.89
The uncounted dead--American civilians dying overseas. Public Health Rep (1992) 0.88
Multiyear prospective study of intestinal parasitism in a cohort of Peace Corps volunteers in Guatemala. J Clin Microbiol (2001) 0.85
Serum antibodies to Giardia lamblia by age in populations in Colorado and Thailand. West J Med (1990) 0.84
Management of the returning traveler with diarrhea. Therap Adv Gastroenterol (2009) 0.81
Is it safe to travel? J R Soc Med (1994) 0.80
Defining infections in international travellers through the GeoSentinel surveillance network. Nat Rev Microbiol (2009) 0.80
Travel risk behaviours and uptake of pre-travel health preventions by university students in Australia. BMC Infect Dis (2012) 0.79
Analysis of the pediatric health information system database as a surveillance tool for travel-associated infectious diseases. Am J Trop Med Hyg (2015) 0.78
Neurologic aspects of infections in international travelers. Neurologist (2005) 0.77
Evaluation of the returned traveler. Yale J Biol Med (1993) 0.77
NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER. Continuum (Minneap Minn) (2006) 0.76
International travellers from New Jersey: piloting a travel health module in the 2011 Behavioral Risk Factor Surveillance System survey. J Travel Med (2016) 0.75
Antibiotics for Travelers: What's Good and What's Not. Curr Infect Dis Rep (2004) 0.75
Immunizations in pediatrics: an update. Can Fam Physician (1990) 0.75
Travel medicine for the extreme traveler. Dis Mon (2006) 0.75
Prevalence of gastrointestinal infection among international travellers returning to Canada. Can J Infect Dis (1993) 0.75
Fever in returning travellers due to a noninfectious disease: Two case reports. Can J Infect Dis Med Microbiol (2008) 0.75
American travel deaths in Mexico. Causes and prevention strategies. West J Med (1991) 0.75
Typhoid fever, complicated by myocarditis, in a traveller returning to the UK. BMJ Case Rep (2013) 0.75
President's address: travel medicine and principles of safe travel. Trans Am Clin Climatol Assoc (2008) 0.75
Immunizations for foreign travel. Yale J Biol Med (1993) 0.75
Emporiatrics: The growing area of concern. J Res Med Sci (2014) 0.75
Coughing and fever after surfing in Central America. Wien Klin Wochenschr (2012) 0.75
Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study. Eur J Clin Microbiol Infect Dis (2016) 0.75
Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon. Eur J Biochem (1980) 3.24
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for the mass and sequence analysis of natural and modified oligonucleotides. Nucleic Acids Res (1993) 2.82
Why aircraft disinsection? Bull World Health Organ (2000) 2.56
Imported malaria (1985-95): trends and perspectives. Bull World Health Organ (1999) 2.50
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
Reproducibility of 24-hour intraesophageal pH monitoring in pediatric patients. Pediatrics (1998) 2.12
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med (2008) 2.03
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med (2012) 1.76
Risk and aetiology of diarrhoea at various tourist destinations. Lancet (2000) 1.72
Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya. J Infect Dis (1987) 1.71
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health (1996) 1.65
Epidemiology of diarrhea in travelers. JAMA (1983) 1.64
Epidemiology of cholera in travellers, and conclusions for vaccination recommendations. Br Med J (Clin Res Ed) (1983) 1.63
Antacids--a risk factor in travellers brucellosis? Scand J Infect Dis (1977) 1.62
Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Lancet (1986) 1.61
Malaria chemoprophylaxis with mefloquine. Lancet (1991) 1.55
'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? Int J Epidemiol (1985) 1.52
Physical activity assessment using a pedometer and its comparison with a questionnaire in a large population survey. Am J Epidemiol (1995) 1.50
Electrogastrography versus gastric emptying scintigraphy in children with symptoms suggestive of gastric motility disorders. J Pediatr Gastroenterol Nutr (2000) 1.45
Hepatitis B vaccination of high-risk individuals in the canton of Zurich. Eur J Clin Microbiol (1983) 1.43
[Inter-disciplinary European guidelines on surgery of severe obesity]. Vnitr Lek (2008) 1.42
Feasibility of a rapid dipstick antigen-capture assay for self-testing of travellers' malaria. Trop Med Int Health (1999) 1.40
Typhoid vaccine, for whom? Lancet (1982) 1.38
Travel health insurance: indicator of serious travel health risks. J Travel Med (2003) 1.38
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med (2006) 1.38
The accuracy of free-hand cup positioning--a CT based measurement of cup placement in 105 total hip arthroplasties. Int Orthop (2004) 1.38
Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population. Am J Clin Nutr (1992) 1.36
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (1999) 1.36
[Risk of disease in 10,500 travelers to tropical countries and 1,300 tourists to North America]. Schweiz Med Wochenschr (1978) 1.36
Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag. Aviat Space Environ Med (2001) 1.33
MalaQuick versus ParaSight F as a diagnostic aid in travellers' malaria. Trans R Soc Trop Med Hyg (1999) 1.30
Trends in cardiovascular risk factors (1984-1993) in a Swiss region: results of three population surveys. Prev Med (1997) 1.25
Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) (2007) 1.19
Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ (1990) 1.19
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Arch Intern Med (2000) 1.12
[To which travelers abroad should immunization against hepatitis be recommended?]. Soz Praventivmed (1982) 1.12
Travellers' diarrhoea. Baillieres Clin Gastroenterol (1987) 1.11
Epidemiologic studies of travelers' diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis (1986) 1.10
Lactose carrier protein of Escherichia coli. Transport and binding of 2'-(N-dansyl)aminoethyl beta-D-thiogalactopyranoside and p-nitrophenyl alpha-d-galactopyranoside. Biochemistry (1979) 1.09
Prevalence of Tropheryma whipplei DNA in patients with various gastrointestinal diseases and in healthy controls. Infection (2003) 1.09
[How great is the risk of hepatitis due to travel? Retrospective study in the region of Zurich 1971-1976]. Schweiz Med Wochenschr (1977) 1.08
Primmorphs generated from dissociated cells of the sponge Suberites domuncula: a model system for studies of cell proliferation and cell death. Mech Ageing Dev (1998) 1.07
Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg (2000) 1.07
Conservative management of intragastric migration of Swedish adjustable gastric band by endoscopic retrieval. Gastrointest Endosc (2001) 1.05
Local anaesthetic injection with and without corticosteroids for subacromial impingement syndrome. Int Orthop (2000) 1.05
Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther (2001) 1.05
In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother (2001) 1.03
Importation of poliomyelitis to industrialised nations between 1975 and 1984: evaluation and conclusions for vaccination recommendations. Br Med J (Clin Res Ed) (1987) 1.01
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04. Vaccine (2004) 1.01
Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data. HIV Med (2010) 1.00
Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr Infect Dis J (1991) 1.00
Use of conscious sedation for lower and upper gastrointestinal endoscopic examinations in children, adolescents, and young adults: a twelve-year review. Gastrointest Endosc (1997) 0.99
Effectiveness of personal protection measures against mosquito bites for malaria prophylaxis in travelers. J Travel Med (1998) 0.99
Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. Swiss HIV Cohort Study. AIDS (1998) 0.98
Hospital vocational training. Local audits are helpful. BMJ (1994) 0.98
Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers. Cancer Chemother Pharmacol (2009) 0.98
Cathepsin, a major protease of the marine sponge Geodia cydonium: purification of the enzyme and molecular cloning of cDNA. Mol Mar Biol Biotechnol (1997) 0.97
Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum. Toxicology (1998) 0.97
Time trend and determinants of blood lead levels in a Swiss population over a transition period (1984-1993) from leaded to unleaded gasoline use. Environ Res (1995) 0.96
Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate. Antimicrob Agents Chemother (1986) 0.96
Risks of hepatitis B in travelers as compared to immunization status. J Travel Med (2000) 0.96
Production of the cytostatic agent aeroplysinin by the sponge Verongia aerophoba in in vitro culture. Comp Biochem Physiol C (1992) 0.96
Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr (2000) 0.95
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int (1998) 0.95
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med (1998) 0.95
Stand-by treatment of malaria in travellers: a review. J Trop Med Hyg (1994) 0.95
Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull World Health Organ (1995) 0.94
Salmonella and Shigella infections in Switzerland, with special reference to typhoid vaccination for travellers. Scand J Infect Dis (1981) 0.93
Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol (1990) 0.93
Tolerance of mefloquine by SwissAir trainee pilots. Am J Trop Med Hyg (1997) 0.92
Formation of spicules by sclerocytes from the freshwater sponge Ephydatia muelleri in short-term cultures in vitro. In Vitro Cell Dev Biol Anim (1996) 0.92
PS II model-based simulations of single turnover flash-induced transients of fluorescence yield monitored within the time domain of 100 ns-10 s on dark-adapted Chlorella pyrenoidosa cells. Photosynth Res (2008) 0.92
The putative sponge aggregation receptor. Isolation and characterization of a molecule composed of scavenger receptor cysteine-rich domains and short consensus repeats. J Cell Sci (1998) 0.92
Differential expression of allograft inflammatory factor 1 and of glutathione peroxidase during auto- and allograft response in marine sponges. J Cell Sci (1999) 0.91
Influence of formycin B on polyadenosine diphosphoribose synthesis in vitro and in vivo. Cancer Res (1975) 0.91
[Cup placement in hip replacement surgery -- A comparison of free-hand and computer assisted cup placement in total hip arthroplasty -- a multi-center study]. Z Orthop Ihre Grenzgeb (2004) 0.90
Body mass index: comparing mean values and prevalence rates from telephone and examination surveys. Rev Epidemiol Sante Publique (2001) 0.90
Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy. J Infect Dis (1988) 0.90
Switzerland's participation in MONICA. Soz Praventivmed (1985) 0.89
[Is epidural injection treatment with hypertonic saline solution in intervertebral disk displacement useful? (The effect of NaCl solution on intervertebral disk tissue)]. Z Orthop Ihre Grenzgeb (1990) 0.89
Surgical or conservative treatment for chronic rotator cuff calcifying tendinitis--a matched-pair analysis of 100 patients. Arch Orthop Trauma Surg (2001) 0.89
One-year prevalence of low back pain in two Swiss regions: estimates from the population participating in the 1992-1993 MONICA project. Spine (Phila Pa 1976) (2000) 0.89